TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -3 | -7 | -17 | 7 | 3 | -12 | -5 |
| P | %wins | 50 | 0 | 0 | 50 | 50 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/16 15:16 | 6/14/16 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Baum Charles M | CA | DO | P,CEO | P | 141 | 7.05 | 7 | 20 | 70 | 49 | D | -64 | -75 | -78 | -65 | -65 | -56 | -61 | -18 | -5 | -11 | -30 | -33 | -21 | |
11/26/13 16:59 | 11/26/13 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Baum Charles M | CA | DO | P,CEO | P | 85 | 16.96 | 1 | 5 | New | 5 | D | 100 | 4 | -1 | -3 | 2 | 0 | -2 | -4 | 46 | 27 | -12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |